DEZHAN HEALTHCARE(SZ:000813) Shang Hai Zheng Quan Bao·2025-07-31 19:16Core Viewpoint - The company has completed the cancellation of repurchased shares, which amounts to 67,850,450 shares, representing 3.13% of the total share capital before cancellation [2][5]. Group 1: Share Repurchase Implementation - The company approved a share repurchase plan at the 2024 first extraordinary general meeting, allowing for the repurchase of shares using between RMB 200 million and RMB 300 million within 12 months [3]. - The repurchase price was set at a maximum of RMB 3.59 per share, with the funds sourced from the company's own funds and loans from financial institutions [3]. - The actual repurchase period was from September 3, 2024, to July 15, 2025, with a total of 67,850,450 shares repurchased at an average price of RMB 2.96 per share, totaling RMB 200,884,766.50 [4]. Group 2: Share Cancellation Details - The cancellation of the repurchased shares was confirmed by the China Securities Depository and Clearing Corporation on July 30, 2025, with the total share capital reduced from 2,164,955,990 shares to 2,097,105,540 shares [2][5]. - The shares were canceled from both self-funded and loan accounts, with 28,567,500 shares from self-funding and 39,282,950 shares from loans [2][5]. Group 3: Impact on Shareholder Equity - The cancellation of shares is expected to enhance earnings per share and improve shareholder returns without adversely affecting the company's financial, operational, or debt obligations [6]. - The cancellation will not change the company's control or affect its listing status [6]. Group 4: Future Arrangements - The company will amend relevant provisions in its articles of association and complete necessary business registration and filing procedures as per legal requirements [6].